Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (766,491)	$ (625,150)
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
Depreciation and amortization	19,404	14,284
Net realized losses (gains) on the sale of securities	(10,764)	(102)
Amortization of investment securities, net	7,397	9,420
Deferred acquisition costs capitalized	(127,119)	(74,754)
Deferred acquisition costs amortized	89,099	58,328
Interest credited on deposit type contracts	32,531	11,936
(Increase) decrease in operating assets:
Investment income due and accrued	(4,177)	(2,598)
Reinsurance related assets	(116,698)	(6,652)
Pre-paid expenses	50,724	(31,006)
Other assets	6,802	40,341
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	1,039,565	530,478
Advance premiums	25,848	18,167
Other liabilities	(3,097)	647
Accounts payable and accrued expenses	(45,891)	(6,672)
Net cash provided by (used in) operating activities	197,133	(63,333)
Cash Flows from Investing Activities:
Purchase of fixed income investments	(1,512,774)	(498,652)
Purchase of equity investments	(805,227)	(408,342)
Proceeds from fixed income sales and repayments	467,504	226,427
Proceeds from equity sales and repayments	92,247
Purchase of property, equipment and software		(21,586)
Net cash (used in) investing activities	(1,758,250)	(702,153)
Cash Flows from Financing Activities:
Receipts on deposit-type contracts	949,295	213,522
Withdrawals on deposit-type contracts	(153,699)	(26,220)
Proceeds received from exercise of warrants, net of costs of issuance	1,834,677	1,864,797
Net cash provided by financing activities	2,630,273	2,052,099
Net increase in cash and cash equivalents	1,069,156	1,286,613
Cash and Cash Equivalents:
Beginning	2,466,526	575,005
Ending	$ 3,535,682	$ 1,861,618